Drug – bio-affecting and body treating compositions – Preparations characterized by special physical form – Tablets – lozenges – or pills
Reexamination Certificate
2003-01-30
2010-11-16
Sheikh, Humera N (Department: 1615)
Drug, bio-affecting and body treating compositions
Preparations characterized by special physical form
Tablets, lozenges, or pills
C424S422000, C424S443000, C424S449000, C424S451000, C424S452000, C424S465000, C424S468000, C424S489000
Reexamination Certificate
active
07833546
ABSTRACT:
The invention relates to a method for producing a pharmaceutical dosage form as tablets, pellets and/or in the form of an active ingredient-containing matrix, whereby the tablets, pellets and/or active ingredient-containing matrix contain a pharmaceutical active ingredient and a copolymer serving as a coating agent and/or binding agent, and optionally contain a core and pharmaceutically common additives. According to the invention, the copolymer, the pharmaceutical active ingredient, the optionally present core and/or the pharmaceutically common additives are processed using known techniques by melting, injection molding, extrusion, wet granulation, casting, dipping, spreading out, spraying on, or pressing to form tablets, pellets and/or an active ingredient-containing matrix. The inventive method is characterized in that a copolymer is used that consists of 20 to 34 wt. % methacrylic acid, 20 to 69 wt. % methylacrylate and 0 to 40 wt. % ethylacrylate and, optionally, of 0 to 10 wt. % of additional vinylically copolymerizable monomers with the provision that the glass transition temperature of the copolymer is no higher than 60° C. according to ISO 11357-2, Item 3.3.3. The invention also relates to the pharmaceutical dosage form produced according to this method, said copolymer and the use thereof.
REFERENCES:
patent: 5548033 (1996-08-01), Vetter et al.
patent: 5644011 (1997-07-01), Lehmann et al.
patent: 5705189 (1998-01-01), Lehmann et al.
patent: 5837780 (1998-11-01), Albrecht et al.
patent: 5993849 (1999-11-01), Assmus et al.
patent: 6040387 (2000-03-01), Albrecht et al.
patent: 6063399 (2000-05-01), Assmus et al.
patent: 6287470 (2001-09-01), Vetter et al.
patent: 6555195 (2003-04-01), Zietek et al.
patent: 6576255 (2003-06-01), Petereit et al.
patent: 6632454 (2003-10-01), Beckert et al.
patent: 6803416 (2004-10-01), Schultes et al.
patent: 6878387 (2005-04-01), Petereit et al.
patent: 2002/0160042 (2002-10-01), Petereit et al.
patent: 2003/0060381 (2003-03-01), Meier et al.
patent: 2003/0152627 (2003-08-01), Beckert et al.
patent: 2004/0104501 (2004-06-01), Petereit et al.
patent: 2005/0019381 (2005-01-01), Petereit et al.
patent: 2005/0089571 (2005-04-01), Beckert et al.
patent: 2005/0154165 (2005-07-01), Petereit et al.
patent: 704 207 (1996-04-01), None
U.S. Appl. No. 10/532,831, filed Apr. 26, 2005, Petereit, et al.
U.S. Appl. No. 10/512,860, filed Nov. 15, 2004, Petereit, et al.
U.S. Appl. No. 09/515,098, filed Feb. 29, 2000, Assmus, et al.
U.S. Appl. No. 09/868,644, filed Jun. 28, 2001, Hoess, et al.
E. Penzel, et al. “The glass transition temperature of random copolymers:1. experimental data and the gordon-taylor equation”, POLYMER , vol. 38, No. 2, pp. 325-337 1997.
Blesing Ingrid
Grimm Stefan
Meier Christian
Petereit Hans-Ulrich
Schnabel Michael
Evonik Roehm GmbH
Oblon, Spivak McClelland, Maier & Neustadt, L.L.P.
Sheikh Humera N
LandOfFree
Pharmaceutical dosage form and method for the production... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Pharmaceutical dosage form and method for the production..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Pharmaceutical dosage form and method for the production... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4220781